1. Home
  2. ZEO vs PPBT Comparison

ZEO vs PPBT Comparison

Compare ZEO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • PPBT
  • Stock Information
  • Founded
  • ZEO 2005
  • PPBT 2010
  • Country
  • ZEO United States
  • PPBT Israel
  • Employees
  • ZEO N/A
  • PPBT N/A
  • Industry
  • ZEO
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • PPBT Health Care
  • Exchange
  • ZEO NYSE
  • PPBT Nasdaq
  • Market Cap
  • ZEO 55.5M
  • PPBT 6.2M
  • IPO Year
  • ZEO N/A
  • PPBT N/A
  • Fundamental
  • Price
  • ZEO $2.49
  • PPBT $2.40
  • Analyst Decision
  • ZEO
  • PPBT Strong Buy
  • Analyst Count
  • ZEO 0
  • PPBT 1
  • Target Price
  • ZEO N/A
  • PPBT $33.00
  • AVG Volume (30 Days)
  • ZEO 89.9K
  • PPBT 20.0K
  • Earning Date
  • ZEO 08-18-2025
  • PPBT 08-15-2025
  • Dividend Yield
  • ZEO N/A
  • PPBT N/A
  • EPS Growth
  • ZEO N/A
  • PPBT N/A
  • EPS
  • ZEO N/A
  • PPBT N/A
  • Revenue
  • ZEO $61,885,622.00
  • PPBT N/A
  • Revenue This Year
  • ZEO N/A
  • PPBT N/A
  • Revenue Next Year
  • ZEO N/A
  • PPBT N/A
  • P/E Ratio
  • ZEO N/A
  • PPBT N/A
  • Revenue Growth
  • ZEO N/A
  • PPBT N/A
  • 52 Week Low
  • ZEO $1.05
  • PPBT $2.00
  • 52 Week High
  • ZEO $4.75
  • PPBT $13.95
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 43.01
  • PPBT 47.27
  • Support Level
  • ZEO $2.66
  • PPBT $2.35
  • Resistance Level
  • ZEO $2.80
  • PPBT $2.58
  • Average True Range (ATR)
  • ZEO 0.28
  • PPBT 0.12
  • MACD
  • ZEO -0.09
  • PPBT 0.01
  • Stochastic Oscillator
  • ZEO 1.65
  • PPBT 43.75

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: